Business, energy, technology, markets and global industry news from Business News Today

Institut Curie

PharmaDeviceNews Institut Curie
One Biosciences’ FFPE single-cell tumour profiling research highlights how routine pathology samples could support deeper analysis of cancer cells, immune populations and the tumour microenvironment across multiple cancer types. Representative image.
Medical Devices & Diagnostics

Can One Biosciences bring single-cell transcriptomics into routine cancer pathology?

One Biosciences reports an FFPE single-cell workflow across six cancers, but clinical utility and prospective validation remain the next tests.

Read More
Representative image: Single-cell tumor profiling and antibody-drug conjugate research illustrate how One Biosciences aims to improve ADC biomarker discovery, treatment-response analysis and future patient selection.
Medical Devices & Diagnostics

One Biosciences advances OneMap platform toward clinical-grade ADC biomarker use

See how One Biosciences is using single-cell profiling to improve ADC biomarkers, patient selection and future companion diagnostics.

Read More